Science Explorer Back to mapMap
Discussion

Kyowa Kirin (France)

World rank, all time
#31,492
of 34,923
Rank in France
#884
of 943
Research works
139
▲ 39% vs 2018-21
Citations
1.1k
7.8 per fractional work
Top-10% rate
5.1%
all institutions 10.0%
vs its own fields
0.88×
1.00× is exactly expected
Open access
53%
world 40%
International
58%
world 18%

Which fields of science does Kyowa Kirin (France) work in?

In 2022-now, 48% of research at Kyowa Kirin (France) is in Health Sciences, 29% in Life Sciences. Its largest fields are Medicine (45%), Biochemistry, Genetics and Molecular Biology (15%), Agricultural and Biological Sciences (7%). It does 1.8× the world's share of Health Sciences.

Health Sciences: 20 fractional works · 48.1% of its workMedicine: 19 fractional works · 44.9% of its workNeurology: 3 fractional works · 6.7% of its workRadiology, Nuclear Medicine and Imaging: 2 fractional works · 5.7% of its workOncology: 2 fractional works · 5.4% of its workDermatology: 2 fractional works · 4.5% of its workNephrology: 2 fractional works · 3.6% of its workPathology and Forensic Medicine: 1 fractional works · 3.0% of its workHematology: 1 fractional works · 2.3% of its workPhysiology: 1 fractional works · 1.5% of its workRheumatology: 1 fractional works · 1.3% of its workInfectious Diseases: 1 fractional works · 1.3% of its workPsychiatry and Mental health: 0 fractional works · 1.1% of its workGenetics: 0 fractional works · 1.1% of its workPharmacology: 0 fractional works · 0.9% of its workImmunology and Allergy: 0 fractional works · 0.9% of its workOphthalmology: 0 fractional works · 0.8% of its workFamily Practice: 0 fractional works · 0.7% of its workPulmonary and Respiratory Medicine: 0 fractional works · 0.7% of its workSurgery: 0 fractional works · 0.7% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 0.7% of its workEpidemiology: 0 fractional works · 0.4% of its workHepatology: 0 fractional works · 0.4% of its workHealth Informatics: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.8% of its workNursing: 1 fractional works · 2.4% of its workNutrition and Dietetics: 1 fractional works · 2.4% of its workVeterinary: 0 fractional works · 0.5% of its workSmall Animals: 0 fractional works · 0.5% of its workHealth Professions: 0 fractional works · 0.3% of its workPhysical Therapy, Sports Therapy and Rehabilitation: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.1% of its workLife Sciences: 12 fractional works · 29.3% of its workBiochemistry, Genetics and Molecular Biology: 6 fractional works · 14.8% of its workMolecular Biology: 5 fractional works · 11.0% of its workGenetics: 1 fractional works · 1.9% of its workCancer Research: 0 fractional works · 0.7% of its workBiophysics: 0 fractional works · 0.4% of its workCell Biology: 0 fractional works · 0.4% of its workPhysiology: 0 fractional works · 0.4% of its workAgricultural and Biological Sciences: 3 fractional works · 7.0% of its workEcology, Evolution, Behavior and Systematics: 1 fractional works · 2.2% of its workAnimal Science and Zoology: 0 fractional works · 1.2% of its workInsect Science: 0 fractional works · 1.2% of its workPlant Science: 0 fractional works · 1.2% of its workFood Science: 0 fractional works · 0.8% of its workSmaller subfields together: 0 fractional works · 0.4% of its workImmunology and Microbiology: 2 fractional works · 4.9% of its workImmunology: 2 fractional works · 4.9% of its workNeuroscience: 1 fractional works · 1.7% of its workNeurology: 0 fractional works · 1.2% of its workCellular and Molecular Neuroscience: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.1% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 1.0% of its workPharmacology: 0 fractional works · 0.6% of its workToxicology: 0 fractional works · 0.4% of its workPhysical Sciences: 8 fractional works · 19.0% of its workEngineering: 3 fractional works · 6.5% of its workBiomedical Engineering: 1 fractional works · 2.2% of its workMechanical Engineering: 1 fractional works · 1.7% of its workCivil and Structural Engineering: 0 fractional works · 1.2% of its workControl and Systems Engineering: 0 fractional works · 0.5% of its workIndustrial and Manufacturing Engineering: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.5% of its workMathematics: 2 fractional works · 4.9% of its workStatistics and Probability: 2 fractional works · 4.9% of its workEnvironmental Science: 2 fractional works · 3.7% of its workNature and Landscape Conservation: 1 fractional works · 2.4% of its workEcology: 0 fractional works · 1.0% of its workSmaller subfields together: 0 fractional works · 0.3% of its workComputer Science: 1 fractional works · 2.0% of its workArtificial Intelligence: 1 fractional works · 1.3% of its workComputational Theory and Mathematics: 0 fractional works · 0.7% of its workChemical Engineering: 0 fractional works · 0.8% of its workCatalysis: 0 fractional works · 0.8% of its workChemistry: 0 fractional works · 0.6% of its workOrganic Chemistry: 0 fractional works · 0.6% of its workMaterials Science: 0 fractional works · 0.5% of its workBiomaterials: 0 fractional works · 0.3% of its workMaterials Chemistry: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.0% of its workSocial Sciences: 2 fractional works · 3.6% of its workDecision Sciences: 1 fractional works · 1.3% of its workStatistics, Probability and Uncertainty: 0 fractional works · 0.8% of its workManagement Science and Operations Research: 0 fractional works · 0.5% of its workPsychology: 0 fractional works · 0.8% of its workClinical Psychology: 0 fractional works · 0.4% of its workApplied Psychology: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.1% of its workArts and Humanities: 0 fractional works · 0.6% of its workEconomics, Econometrics and Finance: 0 fractional works · 0.4% of its workEconomics and Econometrics: 0 fractional works · 0.4% of its workSocial Sciences: 0 fractional works · 0.3% of its workSociology and Political Science: 0 fractional works · 0.3% of its workBusiness, Management and Accounting: 0 fractional works · 0.1% of its workALL ITS WORKKyowa Kirin(France)42fractional works, 2022-now
Life Sciences29%Physical Sciences19%Health Sciences48%Social Sciences4%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 22 fields, with their numbers
    1. Medicine1944.9%
    2. Nursing12.4%
    3. Veterinary00.5%
    4. Health Professions00.3%
    1. Biochemistry, Genetics and Molecular Biology614.8%
    2. Agricultural and Biological Sciences37.0%
    3. Immunology and Microbiology24.9%
    4. Neuroscience11.7%
    5. Pharmacology, Toxicology and Pharmaceutics01.0%
    1. Engineering36.5%
    2. Mathematics24.9%
    3. Environmental Science23.7%
    4. Computer Science12.0%
    5. Chemical Engineering00.8%
    6. Chemistry00.6%
    7. Materials Science00.5%
    1. Decision Sciences11.3%
    2. Psychology00.8%
    3. Arts and Humanities00.6%
    4. Economics, Econometrics and Finance00.4%
    5. Social Sciences00.3%
    6. Business, Management and Accounting00.1%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 1.47× its world share, 3 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 2.77× its world share, 6 worksBiochemistry, Geneti…Immunology and Microbiology: 4.82× its world share, 2 worksImmunology and Micro…Neuroscience: 1.02× its world share, 1 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 2.80× its world share, 0 worksPharmacology, Toxico…Chemical Engineering: 2.26× its world share, 0 worksChemical EngineeringChemistry: 0.38× its world share, 0 worksChemistryComputer Science: 0.26× its world share, 1 worksComputer ScienceEngineering: 0.43× its world share, 3 worksEngineeringEnvironmental Science: 0.74× its world share, 2 worksEnvironmental ScienceMaterials Science: 0.15× its world share, 0 worksMaterials ScienceMathematics: 4.18× its world share, 2 worksMathematicsHealth Professions: 0.13× its world share, 0 worksHealth ProfessionsMedicine: 2.34× its world share, 19 worksMedicineNursing: 4.92× its world share, 1 worksNursingVeterinary: 3.48× its world share, 0 worksVeterinaryArts and Humanities: 0.20× its world share, 0 worksArts and HumanitiesBusiness, Management and Accounting: 0.04× its world share, 0 worksBusiness, Management…Decision Sciences: 1.38× its world share, 1 worksDecision SciencesEconomics, Econometrics and Finance: 0.22× its world share, 0 worksEconomics, Econometr…Psychology: 0.27× its world share, 0 worksPsychologySocial Sciences: 0.02× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Nursing, 4.9×. Every wedge is a field page.

All 22 fields, with their numbers
  1. Nursing4.92×1 works
  2. Immunology and Microbiology4.82×2 works
  3. Mathematics4.18×2 works
  4. Veterinary3.48×0 works
  5. Pharmacology, Toxicology and Pharmaceutics2.80×0 works
  6. Biochemistry, Genetics and Molecular Biology2.77×6 works
  7. Medicine2.34×19 works
  8. Chemical Engineering2.26×0 works
  9. Agricultural and Biological Sciences1.47×3 works
  10. Decision Sciences1.38×1 works
  11. Neuroscience1.02×1 works
  12. Environmental Science0.74×2 works
  13. Engineering0.43×3 works
  14. Chemistry0.38×0 works
  15. Psychology0.27×0 works
  16. Computer Science0.26×1 works
  17. Economics, Econometrics and Finance0.22×0 works
  18. Arts and Humanities0.20×0 works
  19. Materials Science0.15×0 works
  20. Health Professions0.13×0 works
  21. Business, Management and Accounting0.04×0 works
  22. Social Sciences0.02×0 works

Who are the top researchers at Kyowa Kirin (France)?

Ranked on the quality score, Hannah Cummings lead among researchers whose main affiliation is Kyowa Kirin (France).

  1. 1 Hannah Cummings France · #4,281,198 worldwide 365 citations · 24 works
All ranked researchers at Kyowa Kirin (France)

What are the most cited papers from Kyowa Kirin (France)?

The most cited paper from Kyowa Kirin (France) is "Klotho converts canonical FGF receptor into a specific receptor for FGF23" (Itaru Urakawa, Yuji Yamazaki, Takashi Shimada et al., 2006), with 1,855 citations. Next come "A Phase I Study of the Anti-CC Chemokine Receptor 4 Antibody, Mogamulizumab, in Combination with Nivolumab in Patients with Advanced or Metastatic Solid Tumors" (158) and "Brodalumab, a human anti-interleukin-17-receptor antibody in the treatment of Japanese patients with moderate-to-severe plaque psoriasis: Efficacy and safety results from a phase II randomized controlled study" (148).

Most cited papers
#PaperReleasedCitations
1 Klotho converts canonical FGF receptor into a specific receptor for FGF23 Itaru Urakawa, Yuji Yamazaki, Takashi Shimada et al. · Nature 29 Oct 2006 1,855
2 A Phase I Study of the Anti-CC Chemokine Receptor 4 Antibody, Mogamulizumab, in Combination with Nivolumab in Patients with Advanced or Metastatic Solid Tumors Toshihiko Doi, Kei Muro, Hiroshi Ishii et al. · Clinical Cancer Research 27 Aug 2019 158
3 Brodalumab, a human anti-interleukin-17-receptor antibody in the treatment of Japanese patients with moderate-to-severe plaque psoriasis: Efficacy and safety results from a phase II randomized controlled study Hidemi Nakagawa, Hiroaki Niiro, Kenji Ootaki · Journal of Dermatological Science 26 Oct 2015 148
4 Mogamulizumab in Combination with Durvalumab or Tremelimumab in Patients with Advanced Solid Tumors: A Phase I Study Dmitriy Zamarin, Omid Hamid, Asha Nayak-Kapoor et al. · Clinical Cancer Research Open access 25 Jun 2020 64
5 The orally‐active and selective c‐Fms tyrosine kinase inhibitor Ki20227 inhibits disease progression in a collagen‐induced arthritis mouse model Hiroaki Ohno, Yasunori Uemura, Hideko Murooka et al. · European Journal of Immunology Open access 17 Dec 2007 64
All 61 most cited papers, with filters and sorting

Which keywords describe research at Kyowa Kirin (France)?

By fractional works in 2022-now, weighted toward what it does more of than the world: Oxidative Stress, Monoclonal Antibodies, Glycosylation, Inflammation, Therapeutic Antibodies, Parkinson's Disease, Mitochondrial Dysfunction and Neurodegeneration.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 39 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 39 words, with their numbers
  1. Oxidative Stress4▲ 5.5×11 topics
  2. Inflammation4▲ 4.0×15 topics
  3. Monoclonal Antibodies3▲ 83×3 topics
  4. Epidemiology3▲ 1.72×16 topics
  5. Glycosylation3▲ 62×3 topics
  6. Therapeutic Antibodies3▲ 88×2 topics
  7. Mitochondrial Dysfunction2▲ 20×3 topics
  8. Parkinson's Disease2▲ 24×4 topics
  9. Neurodegeneration2▲ 18×3 topics
  10. Biomarkers2▲ 6.6×3 topics
  11. Diagnostic Criteria2▲ 20×2 topics
  12. Adaptive Designs2▲ 211×1 topic
  13. Antibody Engineering2▲ 82×1 topic
  14. Cancer2▲ 3.3×10 topics
  15. Dopaminergic Neurons2▲ 71×1 topic
  16. False Discovery Rate2▲ 211×1 topic
  17. Fc Receptors2▲ 82×1 topic
  18. a-Synuclein2▲ 87×1 topic
  19. Chronic Kidney Disease2▲ 16×6 topics
  20. Lymphoma2▲ 26×3 topics
  21. Sustainability2▲ 1.64×5 topics
  22. Cardiovascular Disease2▲ 3.0×6 topics
  23. Genetics2▲ 5.0×5 topics
  24. Quality of Life2▲ 2.5×10 topics
  25. Biodiversity1▲ 4.1×2 topics
  26. Biopharmaceuticals1▲ 58×2 topics
  27. Immunogenicity1▲ 69×2 topics
  28. Nutrition1▲ 7.2×4 topics
  29. Treatment1▲ 2.5×7 topics
  30. Neuroprotection1▲ 7.8×5 topics
  31. Pathogenesis1▲ 5.5×5 topics
  32. Cancer Immunotherapy1▲ 18×2 topics
  33. Immune Dysregulation1▲ 33×2 topics
  34. Therapeutic Targets1▲ 17×6 topics
  35. Gene Therapy1▲ 12×3 topics
  36. Immunotherapy1▲ 3.4×3 topics
  37. Prognostic Factors1▲ 5.6×5 topics
  38. Satoyama1▲ 249×1 topic
  39. landscape conservation1▲ 249×1 topic

Which research topics does Kyowa Kirin (France) publish most on?

By volume in 2022-now: Monoclonal and Polyclonal Antibodies Research, Parkinson's Disease Mechanisms and Treatments, Statistical Methods in Clinical Trials and Urban and spatial planning.

  1. 1 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 2 works
  2. 2 Parkinson's Disease Mechanisms and Treatments Neurology 2 works
  3. 3 Statistical Methods in Clinical Trials Statistics and Probability 2 works
  4. 4 Urban and spatial planning Nature and Landscape Conservation 1 works
  5. 5 Parathyroid Disorders and Treatments Nephrology 1 works
  6. 6 CAR-T cell therapy research Oncology 1 works
  7. 7 Dermatology and Skin Diseases Dermatology 1 works
  8. 8 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 1 works
  9. 9 Protein purification and stability Molecular Biology 1 works
  10. 10 Dialysis and Renal Disease Management Nephrology 1 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available53.3%not open46.7%

World: 40% of research is openly available.

with international co-authors57.8%domestic only42.2%

World: 18% is written across borders.

How has Kyowa Kirin (France)'s research output changed?

Output in 2022-2025 was 39% higher than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Kyowa Kirin (France) as a percentage of every work published that year, 0.00011% in 2024.

still counting0.00020%0.00040%0.00060%Kyowa Kirin (France)0.00020% in 202519801990200020102020

Fractional works of Kyowa Kirin (France) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Neuilly-sur-Seine

All research institutions in Neuilly-sur-Seine

Share Kyowa Kirin (France)'s ranking

Kyowa Kirin (France) on Science Explorer

A card with Kyowa Kirin (France)'s standing and the fields it leads in, for a post or a slide. A link to this page previews as the same card.

Download the card

1200 × 630 PNG, sized for social posts, drawn from the latest snapshot.

Badges for a website1Each links back here and updates with every snapshot

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Kyowa Kirin (France). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.